Gilead Sciences Europe Ltd. Posted July 6, 2026

ACE Portfolio medical strategy lead

Uxbridge, United Kingdom Full time
Medical Affairs

Gilead Sciences Europe Ltd. is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together.

Job Description

The ACE Regional Portfolio Strategy Lead owns and drives the integrated, cross-asset portfolio strategy across the ACE region, ensuring consistent translation of global strategy into actionable, regionally relevant execution guidance.

This role acts as the critical strategic bridge between Global and Country teams, enabling aligned scientific positioning, coordinated execution, and proactive portfolio management across affiliates in a complex and heterogeneous environment.

Key Responsibilities

1. Regional Portfolio Strategy Leadership

Own the ACE-level portfolio strategy across all assets and disease areas.

Translate global strategy into clear, prioritised, and actionable regional guidance to support consistent country execution (e.g., POA alignment).

Ensure coherent portfolio-wide scientific positioning across the region.

2. Strategic Integration & Execution Alignment

Drive alignment across Medical Affairs, Government Affairs, Public Affairs, and other cross-functional stakeholders.

Partner with ACE networks (e.g., CMD TA Leads, GMA Execution Lead) to ensure consistent and high-quality regional execution.

Enable best-practice sharing and adoption across affiliates to reduce variability in execution.

3. Above-Country Scientific & External Engagement

Own above-country relationships and engagement strategy with:

Payers, Access and Government Stakeholders (PAGS)

Guideline committees

Professional associations

Independent Medical Education (IME) providers

Provide regional medical leadership and input into:

Public Affairs / Government Affairs / GV&A strategy

EMA label strategy and timing

4. Portfolio Insights & Decision Support

Deliver portfolio-level insights, analysis, and recommendations to regional leadership.

Identify and monitor emerging regional risks, opportunities, and external trends.

Support proactive, data-driven regional decision-making in an increasingly complex portfolio.

5. Cross-Country Coordination & Issue Management

Drive coordinated, region-wide responses to scientific and strategic challenges affecting multiple affiliates.

Ensure early identification and mitigation of cross-country risks.

Improve speed and quality of decision-making by reducing fragmentation and reactive approaches.

Scope & Impact

Geography: ACE region (multi-country, heterogeneous access and policy landscape)

Portfolio: All assets across disease areas

Level: Enterprise/Regional (SD level)

Impact:

Drives consistency in scientific messaging and execution across affiliates

Enhances strategic clarity and prioritisation at country level

Strengthens external influence and stakeholder alignment

Enables faster, proactive portfolio decision-making

Key Interfaces

Internal

Global Medical Affairs

ACE Medical Leadership (CMD TA Leads, affiliates)

Government Affairs / Public Affairs / GV&A

Commercial and cross-functional regional teams

GMA Execution Lead

External

Payers and policy stakeholders

PAGS

Guideline committees

Professional associations

IME providers

Critical Capabilities & Experience

Technical / Functional

Deep understanding of portfolio strategy and lifecycle management

Strong expertise in Medical Affairs and scientific positioning

Experience with EMA label processes and regional policy environments

Leadership & Strategic Skills

Ability to operate at enterprise/portfolio level rather than single-asset focus

Strong strategic translation skills (global → regional → country)

Proven capability in cross-functional and matrix leadership

Skilled in navigating complexity and heterogeneity across markets

External Engagement

Experience engaging with above-country stakeholders and influencers

Strong understanding of health policy, access, and guideline ecosystems

Success Measures (Typical for Gilead Role Profiles)

Alignment and consistency of portfolio execution across ACE affiliates

Quality and impact of regional strategic guidance (POA alignment)

Effectiveness of cross-country risk identification and mitigation

Strength of external stakeholder engagement and influence

Contribution to regional leadership decision-making and outcomes

Why This Role is Critical

This role addresses a structural gap between global strategy and country execution, ensuring the ACE region can manage increasing portfolio complexity while maintaining consistency, speed, and strategic coherence.

Without it, execution remains fragmented, decision-making reactive, and opportunities for regional scale and influence underleveraged.

The role is based in UK – UK contract. We are pleased to share that Gilead’s Stockley Park and Holborn offices are planning to come together at a new London headquarters at 1 Triton Square, NW1, from approximately Q2 2027. Applicants should consider this planned location change when applying for this role. Gilead operates a flexible working policy, offering a balanced approach with two days of remote working and three days working onsite.

Equal Employment Opportunity (EEO)

It is the policy of Gilead Sciences, Inc. and its subsidiaries and affiliates (collectively "Gilead" or the "Company") to recruit select and employ the most qualified persons available for positions throughout the Company.  Except if otherwise provided by applicable law, all  employment actions relating to issues such as compensation, benefits, transfers, layoffs, returns from layoffs, company-sponsored training, education assistance, social and recreational programs are administered on a non-discriminatory basis (i.e. without regard to protected characteristics or prohibited grounds, which may include an individual’s gender, race, color, national origin, ancestry, religion, creed, physical or mental disability, marital status, sexual orientation, medical condition, veteran status, and age, unless such protection is prohibited by federal, state, municipal, provincial, local or other applicable laws).  Gilead also prohibits discrimination based on any other characteristics protected by applicable laws.

For Current Gilead Employees and Contractors:

Please apply via the Internal Career Opportunities portal in Workday.

Job details

Seniority
Not listed
Function
Medical Affairs
Therapeutic area
Not listed
Location
Uxbridge, United Kingdom
Employment type
Full time

How this role compares

Computed from every other active Medical Affairs role in our database, not just this employer's listings.

We currently track 924 comparable Medical Affairs roles across 130 biopharma companies.

924Comparable roles tracked
799Currently active
130Companies hiring similar roles
58Countries represented

Salary context

175 of 924 peers report a salary range (USD, annualized)

Peers share this role's job function. This posting doesn't list a seniority level, so peers aren't narrowed by seniority either -- the range below may span more levels than usual.

This roleSubject Not listed on this posting
Lowest disclosed · Clinical Coordinator · Pfizer $79,400/yr – $132,400/yr
Peer group range $105,900 – $458,800 (median $232,750)

Where these roles are based

Top locations among the 924 comparable roles

United States379
China's Mainland69
Japan61
China57
India50
Germany40

+ 52 more countries

Seniority mix

502 of 924 peers have a known seniority level

Director148
Manager125
Senior97
Associate55
Associate Director39
Senior Director20
Executive/VP11
Principal5
Intern/Fellow/Postdoc2

Therapeutic area mix

326 of 924 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology114
Immunology52
Neuroscience35
Cardiovascular / CVRM34
Rare Disease21
Respiratory21
Vaccines & Infectious Disease21
Dermatology & Aesthetics20
Ophthalmology4
Gastroenterology4

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

40%similar
Roche Welwyn, Hertfordshire, United Kingdom Director
Same function Same country
40%similar
40%similar
AbbVie Maidenhead, ENGLAND
Same function Same country
40%similar
Amgen Limited Cambridge, United Kingdom Senior
Same function Same country
40%similar
Gilead Sciences Limited London, United Kingdom Director
Same function Same country
40%similar
Gilead Sciences Europe Ltd. Uxbridge, United Kingdom Associate Director
Same function Same country

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

40%
Head, Ophthalmology Precision Medicine, Medical Director (MD)
Roche · Welwyn, Hertfordshire, United Kingdom · Director
Function Therapeutic area Seniority Country
40%
Senior Medical Advisor – Rare Disease & Inflammatory Disease
Amgen Limited · Cambridge, United Kingdom · Senior
Function Therapeutic area Seniority Country
40%
Undergraduate Industrial Placement Materials Scientist
Mylan Pharma UK Limited · Sandwich, United Kingdom · Seniority not listed
Function Therapeutic area Seniority Country
40%
Medical Advisor, Neuropsychiatry
BMS Pharmaceuticals Ltd · Uxbridge, United Kingdom · Associate
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.